Delic Holdings Inc. Acquires Complex Biotech Discovery Ventures Ltd.

Delic Holdings Inc. (DELIC), a publicly traded psychedelic wellness platform based in Vancouver, has acquired all issued and outstanding shares of Complex Biotech Discovery Ventures Ltd. (CBDV), a Vancouver-based licensed psilocybin and cannabis research laboratory, for a closing payment of $7.0 million plus up to $3.0 million of earn-out consideration. CBDV will be rebranded as DELIC Labs and will serve as Delic's R&D and IP engine for psilocybin and cannabis extraction, analytical testing, and chemical process development.